Cargando…
7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
A series of 3H-1,2-benzoxathiepine 2,2-dioxides incorporating 7-acylamino moieties were obtained by an original procedure starting from 5-nitrosalicylaldehyde, which was treated with propenylsulfonyl chloride followed by Wittig reaction of the bis-olefin intermediate. The new derivatives, belonging...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048192/ https://www.ncbi.nlm.nih.gov/pubmed/32079427 http://dx.doi.org/10.1080/14756366.2020.1722658 |
_version_ | 1783502258088968192 |
---|---|
author | Pustenko, Aleksandrs Nocentini, Alessio Balašova, Anastasija Krasavin, Mikhail Žalubovskis, Raivis Supuran, Claudiu T. |
author_facet | Pustenko, Aleksandrs Nocentini, Alessio Balašova, Anastasija Krasavin, Mikhail Žalubovskis, Raivis Supuran, Claudiu T. |
author_sort | Pustenko, Aleksandrs |
collection | PubMed |
description | A series of 3H-1,2-benzoxathiepine 2,2-dioxides incorporating 7-acylamino moieties were obtained by an original procedure starting from 5-nitrosalicylaldehyde, which was treated with propenylsulfonyl chloride followed by Wittig reaction of the bis-olefin intermediate. The new derivatives, belonging to the homosulfocoumarin chemotype, were assayed as inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). Four pharmacologically relevant human (h) isoforms were investigated, the cytosolic hCA I and II and the transmembrane, tumour-associated hCA IX and XII. No relevant inhibition of hCA I and II was observed, whereas some of the new derivatives were effective, low nanomolar hCA IX/XII inhibitors, making them of interest for investigations in situations in which the activity of these isoforms is overexpressed, such as hypoxic tumours, arthritis or cerebral ischaemia. |
format | Online Article Text |
id | pubmed-7048192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-70481922020-03-10 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors Pustenko, Aleksandrs Nocentini, Alessio Balašova, Anastasija Krasavin, Mikhail Žalubovskis, Raivis Supuran, Claudiu T. J Enzyme Inhib Med Chem Research Paper A series of 3H-1,2-benzoxathiepine 2,2-dioxides incorporating 7-acylamino moieties were obtained by an original procedure starting from 5-nitrosalicylaldehyde, which was treated with propenylsulfonyl chloride followed by Wittig reaction of the bis-olefin intermediate. The new derivatives, belonging to the homosulfocoumarin chemotype, were assayed as inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). Four pharmacologically relevant human (h) isoforms were investigated, the cytosolic hCA I and II and the transmembrane, tumour-associated hCA IX and XII. No relevant inhibition of hCA I and II was observed, whereas some of the new derivatives were effective, low nanomolar hCA IX/XII inhibitors, making them of interest for investigations in situations in which the activity of these isoforms is overexpressed, such as hypoxic tumours, arthritis or cerebral ischaemia. Taylor & Francis 2020-02-21 /pmc/articles/PMC7048192/ /pubmed/32079427 http://dx.doi.org/10.1080/14756366.2020.1722658 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Pustenko, Aleksandrs Nocentini, Alessio Balašova, Anastasija Krasavin, Mikhail Žalubovskis, Raivis Supuran, Claudiu T. 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors |
title | 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors |
title_full | 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors |
title_fullStr | 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors |
title_full_unstemmed | 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors |
title_short | 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors |
title_sort | 7-acylamino-3h-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase ix and xii inhibitors |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048192/ https://www.ncbi.nlm.nih.gov/pubmed/32079427 http://dx.doi.org/10.1080/14756366.2020.1722658 |
work_keys_str_mv | AT pustenkoaleksandrs 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors AT nocentinialessio 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors AT balasovaanastasija 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors AT krasavinmikhail 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors AT zalubovskisraivis 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors AT supuranclaudiut 7acylamino3h12benzoxathiepine22dioxidesasnewisoformselectivecarbonicanhydraseixandxiiinhibitors |